GNFT GENFIT S.A. ADRs

Develops biopharmaceutical products for the treatment of cardio metabolic and neurodegenerative diseases This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:GNFT.

$3.93  -0.15 (-3.56%)
As of 03/24/2023 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  France
Country of incorporation:  
IPO date:  01/27/2016
Outstanding shares:  49,834,983
Average volume:  5,128
Market cap:   $203,077,556
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%